Beijing Beilu Pharmaceutical Co., Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 207.51 million compared to CNY 188.04 million a year ago. Revenue was CNY 207.51 million compared to CNY 188.04 million a year ago.

Net income was CNY 11.53 million compared to CNY 12.58 million a year ago. Basic earnings per share from continuing operations was CNY 0.0235 compared to CNY 0.0256 a year ago.